Intravenous administration of iron in epoetin-treated haemodialysis patients - which drugs, which regimen?

被引：33

作者：

Macdougall, IC ^{[1
]}

机构：

[1] Kings Coll Hosp London, Renal Unit, Dept Renal Med, London SE22 8PT, England

来源：

关键词：

D O I：

10.1093/ndt/15.11.1743

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：1743 / 1745

页数：3

共 29 条

[11] GEISSER P, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1439
[12] Dialysate iron therapy: Infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis
Gupta, A
Amin, NB
Besarab, A
Vogel, SE
Divine, GW
Yee, J
Anandan, JV
[J]. KIDNEY INTERNATIONAL, 1999, 55 (05) : 1891 - 1898
[13] INTRAVENOUS IRON DEXTRAN IN CLINICAL MEDICINE
HAMSTRA, RD
BLOCK, MH
SCHOCKET, AL
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (17): : 1726 - 1731
[14] Jayakumar S, 2000, DIALYSIS TRANSPLANT, V29, P198
[15] LANGE R, 1997, PHARM WEEKBLAD, V132, P103
[16] Levin N., 1999, Journal of the American Society of Nephrology, V10, p80A
[17] Strategies for iron supplementation: Oral versus intravenous
Macdougall, IC
[J]. KIDNEY INTERNATIONAL, 1999, 55 : S61 - S66
[18] A randomized controlled study of iron supplementation in patients treated with erythropoietin
Macdougall, IC
Tucker, B
Thompson, J
Tomson, CRV
Baker, LRI
Raine, AEG
[J]. KIDNEY INTERNATIONAL, 1996, 50 (05) : 1694 - 1699
[19] Macdougall IC, 1997, J AM SOC NEPHROL, V8, pA1020
[20] Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit
Macdougall, IC
Chandler, G
Elston, O
Harchowal, J
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (04) : S40 - S46